Bids Are Invited For Acquisition Of Medicines Via Srp

(L1) 6501.226-Ascorbic Acid (Vitamin C), 100 Mg/Ml, Injectable Solution, Ampoule, 5 Ml, Route Of Administration: Intramuscular/Intravenous, Unit. Size: Unitary, (L2) 6501.225-Ascorbic Acid (Vitamin C), 500 Mg, Tablet, Blister, Route Of Administration: Oral, (L3) 6501.266-Amoxicillin Trihydrate, 50 Mg/Ml, Powder For Oral Suspension, Bottle, 150 Ml, Dosing Cup/Syringe, (L4) 6501.3020-Cephalexin Monohydrate, Capsule/Pill, (L5) 6501.2505-Potassium Chloride, 600Mg, Extended Release Coated Pill, Blister/Vial, 08/24/2023, (L6) 6501.556-Diclofenac Potassium, 25 Mg/Ml, 3 Ml, Route Of Administration: Intramuscular, (L7) 6501.3120-Fenoterol, Hydrobromide, 5 Mg/Ml, Solution Drops, Drip Bottle, 20 Ml, Route Of Administration: Oral/Inhalation, (L8) 6501.1348-Glimepiride, 2 Mg, (L9) 6501.2246-Hexamidine, Isethionate + Tetracaine, Hydrochloride, 1 Mg + 0, Mouthwash, Spray Bottle, 50 Ml, Route Of Administration: Oral, (L10) 6501.2822-Linezolid, Tablet Coated, (L11) 6501.842-Metoclopramide, 4 Mg/Ml, 10 Ml, (L12) 6502.1180-Periciazine, 10 Mg/Ml (1%), Ordinance 344/98: C1, (L13) 6502.1181-Periciazine, 40 Mg/ Ml (4%), (L14) 6501.944-Propranolol, 40 Mg, (L15) 6502.1185-Proxymetacaine, Ophthalmic Solution, 5Ml, Route Of Administration: Ophthalmic, (L16) 6501.966-Sulfamethoxazole + Trimethoprim, 40 Mg + 8 Mg/Ml , Oral Suspension, 100 Ml, % Variation Accepted (Upwards) In Primary Packaging Measurement Unit: 20